ImmunityBio (IBRX) Cash & Equivalents Growth (3y) (2016 - 2026)
ImmunityBio (IBRX) Cash & Equivalents Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
24.73% |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-40.88% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-28.55% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
21.66% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-16.07% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
ImmunityBio |
7.55 Bn |
7.17 Bn |
43.97 Mn |
32.36% |
| Date | Value |
|---|
| Mar 31, 2026 |
32.36% |
| Dec 31, 2025 |
-5.49% |
| Sep 30, 2025 |
-16.68% |
| Jun 30, 2025 |
30.53% |
| Mar 31, 2025 |
18.58% |
| Dec 31, 2024 |
-7.48% |
| Sep 30, 2024 |
20.17% |
| Jun 30, 2024 |
15.72% |
| Mar 31, 2024 |
43.86% |
| Dec 31, 2023 |
96.63% |
| Sep 30, 2023 |
28.09% |
| Jun 30, 2023 |
-27.71% |
| Mar 31, 2023 |
14.69% |
| Dec 31, 2022 |
11.35% |
| Sep 30, 2022 |
78.58% |
| Jun 30, 2022 |
53.01% |
| Mar 31, 2022 |
17.76% |
| Dec 31, 2021 |
120.81% |
| Sep 30, 2021 |
61.53% |
| Jun 30, 2021 |
73.33% |
